Publications

Serotype-specific immune responses to pneumococcal conjugate vaccine among children are significantly correlated by individual: Analysis of randomized controlled trial data.

Author(s): Lipsitch M, Li LM, Patterson S, Trammel J, Juergens C, Gruber WC, Scott DA, Dagan R|Journal: Vaccine|PMID: 29248266| January 2018

The magnitude of an individual's serotype-specific immunoglobulin G (IgG) response to a pneumococcal conjugate vaccine (PCV) has been associated with…

Pan-serotype Reduction in Progression of Streptococcus pneumoniae to Otitis Media After Rollout of Pneumococcal Conjugate Vaccines.

Author(s): Lewnard JA, Givon-Lavi N, Weinberger DM, Lipsitch M, Dagan R|Journal: Clin Infect Dis|PMID: 29020218| November 2017

Reductions in otitis media (OM) burden following rollout of pneumococcal conjugate vaccines (PCVs) have exceeded predictions of vaccine impact. In…

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.

Author(s): Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, Rückinger S, Dagan R, Adegbola R, Cutts F, Johnson HL, O'Brien KL, Scott JA, Lipsitch M|Journal: Clin Infect Dis|PMID: 20715907| September 2010

The 92 capsular serotypes of Streptococcus pneumoniae differ greatly in nasopharyngeal carriage prevalence, invasiveness, and disease incidence. There has been…

What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?

Author(s): Colijn C, Cohen T, Fraser C, Hanage W, Goldstein E, Givon-Lavi N, Dagan R, Lipsitch M|Journal: J R Soc Interface|PMID: 19940002| June 2010

The rise of antimicrobial resistance in many pathogens presents a major challenge to the treatment and control of infectious diseases.…